Publications

5491 Results

Genome-wide association studies of survival in 1,520 cancer patients treated with bevacizumab-containing regimens

Authors
J Quintanilha;J Wang;A Sibley;W Xu;O Espin-Garcia;C Jiang;A Etheridge;M Ratain;H-J Lenz;M Bertagnolli;H Kindler;M Dickler;A Venook;J Liu;K Owzar;D Lin;F Innocenti
Journal / Conference
International Journal of Cancer, Jan 15;150(2):279-289. doi: 10.1002/ijc.33810. Epub 2021 Oct 5
Year
2022
Research Committee(s)
Breast and Gastrointestinal
PMID
PMID34528705
Study Number(s)
CTSU/C40503, CTSU/C80405

A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609)

Authors
S Adams;M Othus;S Patel;K Miller;R Chugh;S Schuetze;M Chamberlin;B Haley;A Storniolo;K Cawley;M Reddy;S Anderson;C Zimmerman;A O'Dea;M Mirshahidi;J Ahnert;F Brescia;O Hahn;J Raymond;D Biggs;M Thompson;R Connolly;E Sharon;L Korde;R Gray;E Mayerson;M Plets;CD Blanke;YK Chae;R Kurzrock
Journal / Conference
Clinical Cancer Research, Jan 15;28(2):271-278
Year
2022
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID34716198
PMC
PMC8776596
Study Number(s)
S1609

EGFR High Copy Number Together with High EGFR Protein Expression Predicts Improved Outcome for Cetuximab-based Therapy in Squamous Cell Lung Cancer: Analysis from SWOG S0819, a phase III trial of chemotherapy with or without Cetuximab in advanced NSCLC

Authors
FR Hirsch;MW Redman;J Moon;F Augustino;RS Herbst;T Semrad;M Varella Garcia;C Rivard;K Kelly;DR Gandara;PC Mack
Journal / Conference
Clinical Lung Cancer Jan;23(1):60-71
Year
2022
Research Committee(s)
Lung
PMID
PMID34753703
PMC
PMC8766941
Study Number(s)
S0819

Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer

Authors
H Arai;A Elliott;J Millstein;J Xiu;F-S Ou;F Innocenti;J Wang;F Battaglin;P Jayachandran;N Kawanishi;S Soni;W Zhang;D Sohal;R Goldberg;M Hall;A Scott;M Khushman;J Hwang;E Lou;B Weinberg;A Lockhart;A Shields;J Abraham;D Magee;P Stafford;J Zhang;A Venook;A Venook;W Korn;H-J Lenz
Journal / Conference
Oncogene Jan;41(2):260-267
Year
2022
Research Committee(s)
Gastrointestinal
PMID
PMID34728807
PMC
PMC8738154
Study Number(s)
CTSU/C80405

SWOG 1918: A phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed aggressive non-Hodgkin lymphomas – Aiming to improve therapy, outcomes, and validate a prospective frailty tool

Authors
E Brem;H Li;A Beaven;P Caimi;L Cerchietti;A Alizadeh;R Olin;NL Henry;H Dillon;R Little;C Laubach;M LeBlanc;JW Friedberg;S Smith
Journal / Conference
Journal of Geriatric Oncology, Mar;13(2):258-264
Year
2022
Research Committee(s)
Lymphoma
PMID
PMID34686472
PMC
PMC9879719
Study Number(s)
S1918

A randomized trial of fulvestrant, everolimus and anastrozole in the front line treatment of advanced hormone receptor positive breast cancer, SWOG S1222

Authors
HCF Moore;W Barlow;G Somlo;J Gralow;A Schott;D Hayes;P Kuhn;J Hicks;P Dy;C Yeon;A Conlin;E Balcueva;D Lew;D Tripathy;L Pusztai;G Hortobagyi
Journal / Conference
Clinical Cancer Research Feb 15;28(4):611-617
Year
2022
Research Committee(s)
Breast
PMID
PMID34844978
PMC
PMC9782801
Study Number(s)
S1222

Serum Markers, Obesity and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial

Authors
C Chau;C Till;D Price;P Goodman;M Neuhouser;M Pollak;I Thompson;W Figg
Journal / Conference
Endocrine-Related Cancer Jan 20;29(2):99-109. doi: 10.1530/ERC-21-0107
Year
2022
Research Committee(s)
Cancer Control
PMID
PMID34889205
PMC
PMC8776589
Study Number(s)
SWOG-9217

S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients

Authors
V Shankaran;J Unger;A Darke;J Suga;J Wade;P Kourlas;S Chandana;M O'Rourke;S Satti;D Liggett;D Hershman;S Ramsey
Journal / Conference
Journal of the National Cancer Institute Mar 8;114(3):372-380; Jan 4;djab210. doi: 10.1093/jnci/djab210. Online ahead of print.
Year
2022
Research Committee(s)
Cancer Care Delivery
PMID
PMID34981117
PMC
PMC8902339
Study Number(s)
S1417CD

A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry

Authors
B Darst;R Hughley;A Pfennig;U Hazra;C Fan;P Wan;X Sheng;E Klein;P Goodman;I Thompson;T Rebbeck;D Conti;C Haiman
Journal / Conference
European Urology May;81(5):458-462
Year
2022
Research Committee(s)
Cancer Control and Prevention and Epidemiology
PMID
PMID35031163
PMC
PMC9018520
Study Number(s)
S0000, SWOG-9217

Randomized Phase II Selection Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma: SWOG S1922

Authors
M Overman;K Guthrie;M Salem;K Pedersen;A Kalyan;S Bellasea;P Philip
Journal / Conference
ASCO Gastrointestinal Cancer Symposium (Jan 20-22, 2022, San Francisco, CA), TIPS poster session
Year
2022
Research Committee(s)
Gastrointestinal
Study Number(s)
S1922